Sriparna Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sriparna Das has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Sudipta Maitra
Molecular and Cellular Endocrinology Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, India
4 shared publications - Sambuddha Banerjee
Molecular and Cellular Endocrinology Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, India
3 shared publications - Soumyajyoti Ghosh
Molecular and Cellular Endocrinology Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, India
3 shared publications - Anwesha Samanta
Molecular and Cellular Endocrinology Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, 731235, India
2 shared publications - Angana Pan
Department of Chemistry National Institute of Technology Durgapur Durgapur India
1 shared publication - Anwesha Das
Department of Zoology University of Calcutta Kolkata India
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by Elsevier in Journal of Hazardous Materials Advances
Early innate immune activation links inflammation to mitochondrial and metabolic reprogramming in bisphenol A-exposed macrophages
- 13 November 2026
- Published by Elsevier in Journal of Hazardous Materials Advances
Open AccessEarly innate immune activation links inflammation to mitochondrial and metabolic reprogramming in bisphenol A-exposed macrophages
- 26 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 182
Acrylamide-Induced Neuroendocrine Disruption in Adult Male Zebrafish (Danio rerio): Mechanistic Insights into Locomotor, Neuronal, and Reproductive Impairments
Acrylamide (AA), a well-documented neurotoxin and reproductive toxicant in mammals, poses a potential risk to teleost species, yet its impact on the hypothalamic-pituitary axis and neuroendocrine integrity remains insufficiently explored. This study hypothesises that AA exposure disrupts locomotor behaviour, neurotransmitter homeostasis, and neuroendocrine regulation in adult male zebrafish, impairing reproductive fitness. Using 72 h exposure to 0.5 and 0.75 mM AA, we demonstrate significant alterations in acetylcholinesterase activity, dopamine levels, and Nos1 expression, correlating with locomotor and behavioural deficits. A marked decline in c-Fos immunoreactivity further suggests compromised neuronal activation associated with impaired mating behaviours. Notably, AA perturbs brain neuroendocrine gene expression, including kisspeptins (kiss1, kiss1rb, kiss2, kiss1ra), gnrh3, gonadotropins (fshb, lhb), estrogen receptors (esr1, 2a, 2b), and steroidogenic markers (cyp11a1, cyp17, hsd3b, cyp19a1b), corroborating well with reduced fertilisation efficiency. Mechanistically, oxidative stress characterised by elevated ROS and lipid peroxidation (MDA levels), dysregulated antioxidant systems (catalase, GST, Nox4, Nrf2/Keap1), and altered Cox2 expression drives JNK phosphorylation (activation), Bax/Bcl2 imbalance, Caspase activation, Parp1 cleavage, and DNA fragmentation, triggering brain apoptosis. Intriguingly, increased CD206 and Il-10 expression alongside suppressed proinflammatory mediators potentially hint at altered microglial polarisation and immune modulation in AA-treated brains. While current findings highlight AA-induced neurotoxicity and neuroendocrine disruption in zebrafish, in silico network toxicology analysis could identify AA-susceptible overlapping molecular targets and brain pathways impacting human neuronal and reproductive health. This study offers critical insights into the mechanistic basis of AA toxicity and its relevance in environmental health risk assessment.
- 26 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 182
Acrylamide-Induced Neuroendocrine Disruption in Adult Male Zebrafish (Danio rerio): Mechanistic Insights into Locomotor, Neuronal, and Reproductive Impairments
Acrylamide (AA), a well-documented neurotoxin and reproductive toxicant in mammals, poses a potential risk to teleost species, yet its impact on the hypothalamic-pituitary axis and neuroendocrine integrity remains insufficiently explored. This study hypothesises that AA exposure disrupts locomotor behaviour, neurotransmitter homeostasis, and neuroendocrine regulation in adult male zebrafish, impairing reproductive fitness. Using 72 h exposure to 0.5 and 0.75 mM AA, we demonstrate significant alterations in acetylcholinesterase activity, dopamine levels, and Nos1 expression, correlating with locomotor and behavioural deficits. A marked decline in c-Fos immunoreactivity further suggests compromised neuronal activation associated with impaired mating behaviours. Notably, AA perturbs brain neuroendocrine gene expression, including kisspeptins (kiss1, kiss1rb, kiss2, kiss1ra), gnrh3, gonadotropins (fshb, lhb), estrogen receptors (esr1, 2a, 2b), and steroidogenic markers (cyp11a1, cyp17, hsd3b, cyp19a1b), corroborating well with reduced fertilisation efficiency. Mechanistically, oxidative stress characterised by elevated ROS and lipid peroxidation (MDA levels), dysregulated antioxidant systems (catalase, GST, Nox4, Nrf2/Keap1), and altered Cox2 expression drives JNK phosphorylation (activation), Bax/Bcl2 imbalance, Caspase activation, Parp1 cleavage, and DNA fragmentation, triggering brain apoptosis. Intriguingly, increased CD206 and Il-10 expression alongside suppressed proinflammatory mediators potentially hint at altered microglial polarisation and immune modulation in AA-treated brains. While current findings highlight AA-induced neurotoxicity and neuroendocrine disruption in zebrafish, in silico network toxicology analysis could identify AA-susceptible overlapping molecular targets and brain pathways impacting human neuronal and reproductive health. This study offers critical insights into the mechanistic basis of AA toxicity and its relevance in environmental health risk assessment.
- 5 July 2025
- Published by Elsevier in Environmental Pollution
- Vol. 382, 126779
Detrimental impacts of chronic bisphenol A (BPA) exposure on follicular signalling modulation and ovulatory competence in zebrafish (Danio rerio)
- 5 July 2025
- Published by Elsevier in Environmental Pollution
- Vol. 382, 126779
Detrimental impacts of chronic bisphenol A (BPA) exposure on follicular signalling modulation and ovulatory competence in zebrafish (Danio rerio)
- 25 August 2022
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (11)
Anticancer property and normal cell toxicity profile of pyrrolidine‐based platinum (II) complexes: Their DNA, BSA interaction, and molecular docking
The bioactivity and cytotoxic property of cis‐[Pt (AEP)Cl2] (C‐1); [Pt (AEP)(OH2)2](NO3)2 (C‐2); [Pt (AEP)(GSH) (C‐3)]; and [Pt (AEP)(DL‐meth)]2+(C‐4) (where AEP = 1‐[2‐Aminoethyl] pyrrolidine; GSH = Glutathione; DL‐meth = DL‐methionine) were extensively investigated to find out the more active and less toxic anticancer lead molecules. Spectroscopically characterized Pt (II) complexes (C‐1 to C‐4) were under investigation for their anticancer activity and bio‐molecular interaction with DNA and BSA. The binding property of the complexes toward DNA and BSA were evaluated by UV–Vis, fluorescence spectroscopy, gel electrophoresis, cyclic voltammetry (CV), circular dichroism (CD), and viscometric methods for their pharmacokinetic and pharmacodynamics importance. The BSA binding activity as well as their “Drug reservoir” property of Pt (II) complexes were highlighted for their biological significance. Furthermore, to assess the manner of interaction and also binding strength of the complexes with DNA and BSA molecule, a theoretical approach by molecular docking was performed, utilizing the optimized structure of the complexes. Structural optimization has been performed with density functional theory (DFT) correlation functional (B3LYP) at 6‐31G + (d, p) and LANL2DZ basis set was used for C, N, H, O, S, and metal, respectively. In vitro anticancer activity and level of ROS generation in presence of each complex were explored on A549 cancer cell as well as normal human cell lines HEK293, and their potential cytotoxic property was observed as compared to well‐known recognized anticancer cisplatin.
- 25 August 2022
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (11)
Anticancer property and normal cell toxicity profile of pyrrolidine‐based platinum (II) complexes: Their DNA, BSA interaction, and molecular docking
The bioactivity and cytotoxic property of cis‐[Pt (AEP)Cl2] (C‐1); [Pt (AEP)(OH2)2](NO3)2 (C‐2); [Pt (AEP)(GSH) (C‐3)]; and [Pt (AEP)(DL‐meth)]2+(C‐4) (where AEP = 1‐[2‐Aminoethyl] pyrrolidine; GSH = Glutathione; DL‐meth = DL‐methionine) were extensively investigated to find out the more active and less toxic anticancer lead molecules. Spectroscopically characterized Pt (II) complexes (C‐1 to C‐4) were under investigation for their anticancer activity and bio‐molecular interaction with DNA and BSA. The binding property of the complexes toward DNA and BSA were evaluated by UV–Vis, fluorescence spectroscopy, gel electrophoresis, cyclic voltammetry (CV), circular dichroism (CD), and viscometric methods for their pharmacokinetic and pharmacodynamics importance. The BSA binding activity as well as their “Drug reservoir” property of Pt (II) complexes were highlighted for their biological significance. Furthermore, to assess the manner of interaction and also binding strength of the complexes with DNA and BSA molecule, a theoretical approach by molecular docking was performed, utilizing the optimized structure of the complexes. Structural optimization has been performed with density functional theory (DFT) correlation functional (B3LYP) at 6‐31G + (d, p) and LANL2DZ basis set was used for C, N, H, O, S, and metal, respectively. In vitro anticancer activity and level of ROS generation in presence of each complex were explored on A549 cancer cell as well as normal human cell lines HEK293, and their potential cytotoxic property was observed as compared to well‐known recognized anticancer cisplatin.